Cytokine profile and supposed contribution to scarring in cicatricial pemphigoid

Journal of Oral Pathology and Medicine

Volumn 32, Issue 1, 2003, Pages 34-40

  Caproni, Marzia ^a   Calzolari, Anna ^a   Salvatore, Elisabetta ^a   Giomi, Barbara ^a   Volpi, Walter ^a   D'Agata, Alberino ^a   Santucci, Marco ^a   Fabbri, Paolo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cellular infiltrate; Cicatricial pemphigoid; Cytokine pattern; In situ hybridisation

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 5; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; INTERLEUKIN 4; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BLISTER; CELL ACTIVITY; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EPITHELIUM; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; MALE; MUCOUS MEMBRANE PEMPHIGOID; PEMPHIGOID; PROTEIN EXPRESSION; SCAR FORMATION; SKIN BIOPSY; STAINING; TH2 CELL; BIOSYNTHESIS; BULLOUS PEMPHIGOID; CASE CONTROL STUDY; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MOUTH DISEASE; MOUTH MUCOSA; PHYSIOLOGY; SCAR;

ADULT; AGED; CASE-CONTROL STUDIES; CICATRIX; CYTOKINES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-5; MALE; MIDDLE AGED; MOUTH DISEASES; MOUTH MUCOSA; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PEMPHIGOID, BULLOUS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0037271252     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2003.00028.x     Document Type: Article

References (25)

1. Fleming TE, Korman NJ. Cicatricial pemphigoid. J Am Acad Dermatol 2000; 43: 571-91.
2. Liu Z, Diaz LA, Troy JL, et al. A passive transfer model of the organ specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 1993; 92: 2480-8.
3. Rice BA, Foster CS. Immunopathology of cicatricial pemphigoid affecting the conjunctiva. Ophthalmology 1990; 97: 1476-83.
4. Sacks EH, Jakobiec FA, Wieczorek R, Donnenfeld E, Perry H, Knowles DM. Immunophenotypic analysis of the inflammatory infiltrate in ocular cicatricial pemphigoid. Further evidence for a Tcell mediated disease. Ophthalmology 1989; 96: 236-43.
5. Kaneko F, Minegawa T, Takiguchi J. Role of cell mediated immune reaction in blister formation of bullous pemphigoid. Dermatology 1991; 184: 34-8.
6. Rico MJ, Benning C, Weingart ES, Streilein RD, Hall RP. Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris. Br J Dermatol 1999; 140: 1079-86.
7. Giomi B, Caproni M, Calzolari A, Bianchi B, Fabbri P. Th1, Th2 and Th3 cytokines in the pathogenesis of bullous pemphigoid. J Dermatol Sci 2002.
8. Schmidt E, Bastian B, Dummer R, Tony HP, Broker EB, Zillikens D. Detection of elevated levels of IL-4, IL-6 and IL-10 in blister fluid of bullous pemphigoid. Arch Dermatol Res 1996; 288: 353-7.
9. Rhodes LE, Hashim IA, McLaughlin PJ, Friedmann PS. Blister fluid cytokines in cutaneous inflammatory bullous disorders. Acta Derm Venereol 1999; 79: 288-90.
10. Kumari S, Bhol KC, Rehman F, Foster CS, Ahmed AR. Interleukin 1 components in cicatricial pemphigoid. Role in intravenous immunoglobulin therapy. Cytokine 2001; 14: 218-24.
11. Lee SJ, Li Z, Sherman B, Foster CS. Serum levels of tumour necrosis factor-alpha and interleukin-6 in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 1993; 34: 3522-5.
12. Bernauer W, Wright P, Dart JK, et al. The conjunctiva in acute and chronic mucous membrane pemphigoid: an immunohistochemical analysis. Ophthalmology 1993; 100: 339-46.
13. Elder MJ, Dart JK, Lightman S. Conjunctival fibrosis in ocular cicatricial pemphigoid-the role of cytokines. Exp Eye Res 1997; 65: 165-76.
14. Roberts AB, Sporn MB. The transforming growth factors βs. In: Peptide Growth Factors and Their Receptors. Heidelberg: Springer, 1990; 421-72.
15. Mosmann TR, Sad S. The expanding universe of T cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138-46.
16. Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor beta 1 (TGF-beta1) in autoimmune diseases. J Autoimmun 2000; 14: 23-42.
17. Caproni M, Bianchi B, Amato LE, et al. Th2 like and fibrogenic cytokine expression in cicatricial pemphigoid. Int J Immunopathol Pharmacol 1997; 10: 99-102.
18. Ackerman BA, Ragaz A. The Lives of Lesions, Chronology in Dermatopathology. NY, USA: Masson Publishing, 1984; 21-2.
19. Caproni M, Giomi B, Cardinali C, Salvatore E, et al. Further support for a role for Th2-like cytokines in blister formation of pemphigus. Clin Immunol 2001; 98: 264-71.
20. Takiguchi Y, Itoh N, Suzuki M. The role of IFN-γ in blister formation of bullous pemphigoid. Jpn J Dermatol 1991; 101: 121-7.
21. Budinger L, Borradori L, Yee C, et al. Identification and characterisation of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest 1998; 12: 2082-9.
22. 1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci USA 1993; 90: 10315-9.
23. Frazier K, Williams S, Kothapalli D. Stimulation of fibroblast cell growth matrix production and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996; 107: 404-11.
24. Chomarat P, Rybak ME, Banchereau J. Interleukin-4. In: The Cytokine Handbook. San Diego, CA: Academic Press, 1998, 133-74.
25. Sempowski GD, Derdak S, Phipps RP. Interleukin-4 and Interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J Cell Physiol 1996; 167: 290-6.